abstract |
The compounds are A3 agonists and have the general formula wherein the meanings of the substituents are given in the description. The invention relates to methods for their use and to pharmaceutical compositions containing them. A3 agonists are useful for reduced tissue damage due to tissue ischemia or hypoxia. |